Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer
NCT02211833 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 41
Last updated 2014-08-08
Summary
Exploratory evaluation of safety, tolerability, pharmacokinetics (PK), maximum tolerated dose (MTD), and efficacy of BI 2536 administered in combination with pemetrexed
Conditions
- Carcinoma, Non-Small-Cell Lung
Interventions
- DRUG
-
BI 2536
- DRUG
-
Pemetrexed
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-31
- Primary Completion
- 2009-02-28
More Related Trials
-
A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer
NCT02182232 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
NCT01313663 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
NCT07111520 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
NCT04429087 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer
NCT01004250 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer
NCT07110363 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer
NCT03713944 ·Status: TERMINATED ·Phase: PHASE2
-
Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
NCT00806819 ·Status: COMPLETED ·Phase: PHASE3
-
AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer
NCT02513563 ·Status: COMPLETED ·Phase: PHASE2
-
Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00798603 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer
NCT03472053 ·Status: COMPLETED ·Phase: PHASE2
-
IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
NCT07122687 ·Status: RECRUITING ·Phase: PHASE2
-
A Prospective, Single-Arm, Exploratory Study of IBI363 in ES-SCLC Patients After Immunotherapy Progression
NCT07289048 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer
NCT00099879 ·Status: TERMINATED ·Phase: PHASE2
-
First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
NCT00456261 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy
NCT00533429 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection
NCT02199886 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer
NCT00762034 ·Status: COMPLETED ·Phase: PHASE3
-
Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy
NCT02300298 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)
NCT01069328 ·Status: COMPLETED ·Phase: PHASE1
-
To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC)
NCT00191191 ·Status: COMPLETED ·Phase: PHASE2
-
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
NCT01107626 ·Status: COMPLETED ·Phase: PHASE3
-
Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)
NCT00359450 ·Status: TERMINATED ·Phase: PHASE2
-
Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer
NCT02252796 ·Status: TERMINATED ·Phase: PHASE1
-
Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC
NCT00824408 ·Status: COMPLETED ·Phase: PHASE2